JP2023153423A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023153423A5 JP2023153423A5 JP2023138084A JP2023138084A JP2023153423A5 JP 2023153423 A5 JP2023153423 A5 JP 2023153423A5 JP 2023138084 A JP2023138084 A JP 2023138084A JP 2023138084 A JP2023138084 A JP 2023138084A JP 2023153423 A5 JP2023153423 A5 JP 2023153423A5
- Authority
- JP
- Japan
- Prior art keywords
- hsv
- composition
- infection
- seq
- glycoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025069088A JP2025108645A (ja) | 2017-08-17 | 2025-04-18 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762546648P | 2017-08-17 | 2017-08-17 | |
| US62/546,648 | 2017-08-17 | ||
| US201862701019P | 2018-07-20 | 2018-07-20 | |
| US62/701,019 | 2018-07-20 | ||
| PCT/IB2018/056210 WO2019035066A1 (en) | 2017-08-17 | 2018-08-17 | MODIFIED MHRNA VACCINES ENCODING HERPES SIMPLEX VIRUS GLYCOPROTEINS AND USES THEREOF |
| JP2020509054A JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509054A Division JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025069088A Division JP2025108645A (ja) | 2017-08-17 | 2025-04-18 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023153423A JP2023153423A (ja) | 2023-10-17 |
| JP2023153423A5 true JP2023153423A5 (https=) | 2025-03-12 |
| JP7674760B2 JP7674760B2 (ja) | 2025-05-12 |
Family
ID=65362983
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509054A Active JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
| JP2023138084A Active JP7674760B2 (ja) | 2017-08-17 | 2023-08-28 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
| JP2025069088A Pending JP2025108645A (ja) | 2017-08-17 | 2025-04-18 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020509054A Active JP7386535B2 (ja) | 2017-08-17 | 2018-08-17 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025069088A Pending JP2025108645A (ja) | 2017-08-17 | 2025-04-18 | 単純ヘルペスウイルス糖タンパク質をコードする修飾ｍＲＮＡワクチン及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11141478B2 (https=) |
| EP (2) | EP4242223A3 (https=) |
| JP (3) | JP7386535B2 (https=) |
| CN (2) | CN111246854A (https=) |
| AU (2) | AU2018316811B2 (https=) |
| CA (1) | CA3073161A1 (https=) |
| WO (1) | WO2019035066A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018200737A1 (en) * | 2017-04-26 | 2018-11-01 | Modernatx, Inc. | Herpes simplex virus vaccine |
| AU2018316811B2 (en) | 2017-08-17 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof |
| CN113710267B (zh) * | 2019-03-12 | 2025-05-09 | 生物技术公司 | 用于前列腺癌的治疗性rna |
| CN111568856B (zh) * | 2020-06-24 | 2021-07-06 | 珠海舒桐医疗科技有限公司 | 一种阴道凝胶制剂及其制备方法 |
| WO2022002783A1 (en) * | 2020-06-29 | 2022-01-06 | Glaxosmithkline Biologicals Sa | Adjuvants |
| US12419948B2 (en) | 2020-08-31 | 2025-09-23 | The Broad Institute, Inc. | Immunogenic compositions and use thereof |
| EP4225360A1 (en) | 2020-10-08 | 2023-08-16 | Virothera Limited | Vaccine compositions |
| EP4032546A1 (en) * | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Therapeutic viral vaccine |
| EP4032547A1 (en) * | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Hsv1 fce derived fragements for the treatment of hsv |
| WO2022165313A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| AU2022233957A1 (en) * | 2021-03-11 | 2023-10-12 | Redbiotec Ag | Vaccine compositions and methods for treating hsv |
| WO2024131664A1 (zh) * | 2022-12-19 | 2024-06-27 | 南京奥罗生物科技有限公司 | 单纯疱疹病毒疫苗及其应用 |
| TW202434263A (zh) * | 2023-01-27 | 2024-09-01 | 德商拜恩技術股份公司 | 用於遞送單純疱疹病毒醣蛋白ｃ、醣蛋白ｄ、及醣蛋白ｅ抗原之醫藥組成物及相關方法 |
| WO2024163918A1 (en) | 2023-02-02 | 2024-08-08 | University Of Houston System | Mrna vaccine for herpes simplex virus |
| WO2024249967A1 (en) * | 2023-06-02 | 2024-12-05 | The Trustees Of The University Of Pennsylvania | Rna vaccines encoding herpes simplex virus glycoproteins and uses thereof |
| WO2025030165A1 (en) * | 2023-08-03 | 2025-02-06 | BioNTech SE | Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methods |
| WO2025030103A1 (en) | 2023-08-03 | 2025-02-06 | The Trustees Of The University Of Pennsylvania | Rna compositions encoding herpes simplex virus glycoprotein b antigens and uses thereof |
| AU2024318951A1 (en) | 2023-08-03 | 2026-03-12 | BioNTech SE | Rna compositions encoding herpes simplex virus glycoprotein e and/or glycoprotein i antigens and uses thereof |
| WO2025030097A2 (en) * | 2023-08-03 | 2025-02-06 | BioNTech SE | Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methods |
| WO2025072383A1 (en) | 2023-09-25 | 2025-04-03 | The Broad Institute, Inc. | Viral open reading frames, uses thereof, and methods of detecting the same |
| WO2025097055A2 (en) | 2023-11-02 | 2025-05-08 | The Broad Institute, Inc. | Compositions and methods of use of t cells in immunotherapy |
| WO2025109008A1 (en) | 2023-11-20 | 2025-05-30 | Redbiotec Ag | Novel vaccine compositions and methods for treating hsv |
| WO2025129158A1 (en) | 2023-12-15 | 2025-06-19 | The Broad Institute, Inc. | Engineered arc delivery vesicles and uses thereof |
| WO2025175124A1 (en) * | 2024-02-15 | 2025-08-21 | Albert Einstein College Of Medicine | Recombinant herpes simplex virus glycoprotein b for treatment and prevention of herpes simplex virus infections |
| WO2025212831A1 (en) * | 2024-04-03 | 2025-10-09 | The Trustees Of The University Of Pennsylvania | Methods of inducing an anti-hsv b-cell immune response |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| PL2578685T3 (pl) | 2005-08-23 | 2020-01-31 | The Trustees Of The University Of Pennsylvania | Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania |
| CA2658484A1 (en) * | 2006-07-20 | 2008-01-24 | Vical Incorporated | Compositions and methods for vaccinating against hsv-2 |
| US9284355B2 (en) * | 2006-12-28 | 2016-03-15 | The Trustees Of The University Of Pennsylvania | Herpes simplex virus combined subunit vaccines and methods of use thereof |
| US20130028925A1 (en) | 2006-12-28 | 2013-01-31 | Harvey Friedman | Herpes simplex virus combined subunit vaccines and methods of use thereof |
| EP3756684A1 (en) * | 2009-05-22 | 2020-12-30 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| CN107028886A (zh) | 2009-11-04 | 2017-08-11 | 不列颠哥伦比亚大学 | 含有核酸的脂质粒子及相关的方法 |
| US9192661B2 (en) * | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
| US9770463B2 (en) * | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| WO2012016184A2 (en) | 2010-07-30 | 2012-02-02 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for delivery of active agents |
| HRP20181102T1 (hr) * | 2012-05-16 | 2018-09-07 | Immune Design Corp | Cjepiva za hsv-2 |
| JP6679484B2 (ja) * | 2013-12-11 | 2020-04-15 | ザ ヘンリー エム． ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン インコーポレイテッド | ヒトヘルペスウイルス三量体糖タンパク質Ｂ、三量体ｇＢを含むタンパク質複合体、及びワクチンとしてのそれらの使用 |
| ES2833230T3 (es) * | 2014-05-13 | 2021-06-14 | Univ Pennsylvania | Composiciones que comprenden AVV que expresan construcciones y usos de doble anticuerpo del mismo |
| AU2015327767A1 (en) * | 2014-10-01 | 2017-04-20 | Jingang Medicine (Australia) Pty Ltd | Therapeutic compositions and methods for inducing an immune response to herpes simplex virus type 2 (HSV-2) |
| AU2016253972B2 (en) | 2015-04-27 | 2020-01-02 | Acuitas Therapeutics Inc. | Nucleoside-modified RNA for inducing an adaptive immune response |
| US10758694B2 (en) | 2015-07-09 | 2020-09-01 | Hoyt Medical LLC | Systems and methods for treating an airway using a tapered adapter device |
| AU2016342376A1 (en) * | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Sexually transmitted disease vaccines |
| EP3365009A4 (en) * | 2015-10-22 | 2019-07-03 | ModernaTX, Inc. | VACCINES AGAINST HERPES SIMPLEX VIRUS |
| CA3040337A1 (en) * | 2016-10-26 | 2018-05-03 | Curevac Ag | Lipid nanoparticle mrna vaccines |
| WO2018200737A1 (en) | 2017-04-26 | 2018-11-01 | Modernatx, Inc. | Herpes simplex virus vaccine |
| AU2018316811B2 (en) | 2017-08-17 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof |
-
2018
- 2018-08-17 AU AU2018316811A patent/AU2018316811B2/en active Active
- 2018-08-17 EP EP23169155.1A patent/EP4242223A3/en active Pending
- 2018-08-17 CN CN201880068068.XA patent/CN111246854A/zh active Pending
- 2018-08-17 CN CN202410526392.9A patent/CN118370812A/zh active Pending
- 2018-08-17 EP EP18846061.2A patent/EP3668520A4/en active Pending
- 2018-08-17 JP JP2020509054A patent/JP7386535B2/ja active Active
- 2018-08-17 US US16/640,008 patent/US11141478B2/en active Active
- 2018-08-17 WO PCT/IB2018/056210 patent/WO2019035066A1/en not_active Ceased
- 2018-08-17 CA CA3073161A patent/CA3073161A1/en active Pending
-
2021
- 2021-06-17 US US17/349,929 patent/US11793872B2/en active Active
-
2023
- 2023-08-28 JP JP2023138084A patent/JP7674760B2/ja active Active
- 2023-09-19 US US18/470,325 patent/US20240024463A1/en active Pending
- 2023-10-13 AU AU2023248194A patent/AU2023248194A1/en active Pending
-
2025
- 2025-04-18 JP JP2025069088A patent/JP2025108645A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023153423A5 (https=) | ||
| JP2025108645A5 (https=) | ||
| JP2020531465A5 (https=) | ||
| KR101746872B1 (ko) | 단순 포진 바이러스 유형 2에 대한 백신: 면역 반응을 유도하는 조성물 및 방법 | |
| JP6790189B2 (ja) | Ｈｓｖ−２のためのワクチン | |
| AU2018316811B2 (en) | Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof | |
| Bourne et al. | DNA immunization against experimental genital herpes simplex virus infection | |
| EP2413963B1 (en) | Methods of use for hsv-1 and hsv-2 vaccines | |
| JP2022547313A (ja) | ヒトサイトメガロウイルスワクチン | |
| EP4444345A2 (en) | Herpes simplex virus mrna vaccines | |
| JP5845191B2 (ja) | 単純ヘルペスウイルスワクチン | |
| Wachsman et al. | A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs | |
| Bright et al. | The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27 | |
| US20240156951A1 (en) | Vaccine compositions and methods for treating hsv | |
| Dory et al. | Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins | |
| JP2024534189A5 (https=) | ||
| Lewis et al. | Structural and antigenic identification of the ORF12 protein (αTIF) of equine herpesvirus 1 | |
| JP2014534262A5 (https=) | ||
| US20240016922A1 (en) | Rna vaccines encoding herpes simplex virus glycoproteins and uses thereof | |
| CN121843710A (zh) | 编码单纯疱疹病毒糖蛋白b抗原的rna组合物及其用途 | |
| Bernstein et al. | A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2 | |
| US10166284B1 (en) | Vaccines for herpes simplex virus 1 and 2 | |
| WO2025184664A1 (en) | Multi-antigen herpes simplex vaccine | |
| CN121866069A (zh) | 编码单纯疱疹病毒糖蛋白e和/或糖蛋白i抗原的rna组合物及其用途 | |
| WO2025212831A1 (en) | Methods of inducing an anti-hsv b-cell immune response |